Emerging medication for the treatment of male hypogonadism

Author： Corona Giovanni   Rastrelli Giulia   Vignozzi Linda   Maggi Mario  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.17, Iss.2, 2012-06, pp. : 239-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Testosterone undecanoate in the treatment of male hypogonadism

By Edelstein Daniel   Basaria Shehzad  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2095-2106

Informa Healthcare

Access to resources Recommend Favorite

Topical Testosterone Supplementation for the Treatment of Male Hypogonadism

By Abadilla Katrina A.  

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1591-1603

Adis International

Access to resources Recommend Favorite

Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism

By Harle Lindsey   Basaria Shehzad   Dobs Adrian S  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1751-1759

Informa Healthcare

Access to resources Recommend Favorite

An update on male hypogonadism therapy

By Surampudi Prasanth   Swerdloff Ronald S   Wang Christina  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1247-1264

Informa Healthcare

Access to resources Recommend Favorite

Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer

By Dev Rony   Hui David   Del Fabbro Egidio   Delgado-Guay Marvin O.   Sobti Nikhil   Dalal Shalini   Bruera Eduardo  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1586-1593

Blackwell Publishing

Access to resources Recommend Favorite